Why Harmony Biosciences (HRMY) Stock Is Down 18% Today

Benzinga03:06

Harmony Biosciences Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones01:41 · Ratings

Goldman Sachs Maintains Harmony Biosciences(HRMY.US) With Sell Rating, Maintains Target Price $28

Futu News01:31 · Ratings

Cantor Fitzgerald Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $58

Futu NewsOct 30 21:39 · Ratings

Oppenheimer Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $59

Futu NewsOct 30 20:31 · Ratings

Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating

Futu NewsOct 30 20:31 · Ratings